CRYZL2P-SEC16B readthrough (CRYZL2P-SEC16B)

CRYZL2P-SEC16B readthrough is a gene locus defined by transcription that spans from the pseudogene CRYZL2P through to SEC16B, resulting in a chimeric mRNA[1][3]. This readthrough transcript encodes a protein that shares sequence identity with SEC16B, which itself is a protein involved in organizing endoplasmic reticulum (ER) exit sites and facilitating protein export to the Golgi apparatus, with additional roles in peroxisome biogenesis[2][4][6]. There is no evidence that this readthrough product is a functionally relevant or druggable protein distinct from SEC16B, nor is it recognized as a therapeutic target. Key point: This entry represents a readthrough gene product, not an individual validated or characterized therapeutic target. Structured information or drug development data applies only to SEC16B itself, not to the readthrough entity[1][3][6].

Other names

CRYZL2P-SEC16BCRYZL2P-SEC16B readthrough

None known for drugs targeting this molecule; standard drugs target established protein products, not readthrough fusions like this